Summary:
Bio/Data Corporation’s AGG/PAK 5 Combo Kit is a comprehensive solution for platelet aggregation testing, enhancing laboratory efficiency and aiding in the diagnosis of platelet function disorders.
Takeaways:
- The kit helps detect acquired and inherited platelet disorders, improving diagnostic accuracy.
- It supports the evaluation of anti-platelet therapies, optimizing patient treatment plans.
- Compliance with CLIA and ISTH standards ensures high-quality and reliable testing.
Bio/Data Corporation has introduced the AGG/PAK 5 Combo Kit, a comprehensive solution for platelet aggregation testing designed to enhance laboratory efficiency and provide crucial insights into platelet function disorders. This innovative kit includes ADP (Adenosine-5’-Diphosphate), Arachidonic Acid (Sodium Arachidonate), Collagen (Soluble Calf Skin, Type I), Epinephrine (Adrenaline), and Ristocetin (Ristocetin A Sulfate) Reagents, offering a robust platform for evaluating. platelet function, assessing anti-platelet therapy effectiveness, and aiding in thrombotic event prevention.
The AGG/PAK 5 Combo Kit Provides Info on Clot Formation
The AGG/PAK 5 Combo Kit effectively identifies abnormalities in patients with various acquired and inherited platelet disorders. Laboratories can evaluate patient responses to anti-platelet therapies, ensuring optimal treatment plans. By analyzing platelet aggregation, the Combo Kit provides valuable information on the dynamics of clot formation, aiding in the early detection and prevention of thrombotic events. Additionally, the Combo Kit includes Ristocetin Reagent, necessary for Ristocetin-Induced Platelet Aggregation Testing (RIPA), essential for identifying von Willebrand Disease (vWD).
The Combo Kit meets CLIA, ISTH, and other regulatory requirements, ensuring the. highest standards of quality and compliance, according to the company
